FormulaFolio Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

FormulaFolio Investments’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1K	Hold	2	–	–	﹤0.01%	479
2021 Q1	$1K	Sell	2 -466	-100%	-$227K	﹤0.01%	449
2020 Q4	$226K	Buy	468 +20	+4%	+$10.8K	﹤0.01%	599
2020 Q3	$251K	Buy	+448	New	+$272K	0.01%	271
2019 Q3	–	Sell	-1,919	Closed	-$601K	–	365
2019 Q2	$601K	Buy	1,919 +863	+82%	+$287K	0.03%	189
2019 Q1	$434K	Buy	+1,056	New	+$435K	0.02%	212

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

FormulaFolio Investments's REGN Position: Q2 2021 in Review

FormulaFolio Investments held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2021 at 2 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

FormulaFolio Investments first reported a position in REGN in Q1 2019 and has held it in 6 quarters since. The position peaked at $601K in Q2 2019. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

FormulaFolio Investments held 2 shares of Regeneron Pharmaceuticals worth $1K as of Q2 2021.
FormulaFolio Investments left its Regeneron Pharmaceuticals share count unchanged in Q2 2021.
Regeneron Pharmaceuticals made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #479 holding.
FormulaFolio Investments first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 6 quarters since.
FormulaFolio Investments's Regeneron Pharmaceuticals position peaked at $601K in Q2 2019.
971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.